SEC Filing - Henry Schein

View:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ----------------------------------------------------- FORM 8-K ----------------------------------------------------- CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 July 2, 1999 000-27078 - ------------------------------- ------------------------ Date of Report (Date of (Commission File Number) earliest event reported) HENRY SCHEIN, INC. (Exact name of registrant as specified in its charter) Delaware 11-3136595 - ------------------------------- ------------------------ (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 135 Duryea Road, Melville, NY 11747 - -------------------------------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) (516) 843-5500 - -------------------------------------------------------------------------------- (Registrant's telephone number, including area code)

- -------------------------------------------------------------------------------- ITEM 5. OTHER EVENTS. On July 2, 1999, Henry Schein, Inc. issued the press release filed as an Exhibit to this Current Report on Form 8-K with respect to its consummation of a $130 million dollar private note placement. The notes have a 10 year term and bear interest at the rate of 6.94% per annum. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (a) Not applicable. (b) Not applicable. (c) Exhibits: 99. Press Release, dated July 2, 1999. 2

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, Henry Schein, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HENRY SCHEIN, INC. By: /s/Michael Ettinger -------------------------- Name: Michael Ettinger Title: Vice President and Associate General Counsel Date: July 7, 1999 3

EXHIBIT INDEX DOC. NO. DOCUMENT DESCRIPTION 99 Press Release, dated July 2, 1999.



                                                                      Exhibit 99

                            [Henry Schein Letterhead]

                                            FOR:       Henry Schein, Inc.
                                            CONTACT:   Steven Paladino
                                                       Senior Vice President and
                                                       Chief Financial Officer
                                                       (516) 843-5500

FOR IMMEDIATE RELEASE                                  Susan Vassallo
                                                       Manager, Investor
                                                       and Public Relations
                                                       (516) 843-5562
                                                       svassa@henryschein.com

           HENRY SCHEIN, INC. ANNOUNCES $130 MILLION PRIVATE PLACEMENT
           -----------------------------------------------------------
                  - 10-Year Debt Financing at Attractive Rate -

     Melville, NY -- July 2, 1999 -- Henry Schein, Inc. (Nasdaq:HSIC) announced
today that it has closed a $130 million private placement debt transaction at
par. Chase Securities Inc. acted as agent for the offering.

     The senior note issue has a 10-year life and a coupon rate of 6.94%. Henry
Schein will use the proceeds of the placement for permanent financing for its
recent acquisitions of General Injectables and Vaccines, Inc., and Heiland
Holding GmbH, as well as other corporate purposes.

     Steven Paladino, Senior Vice President and Chief Financial Officer,
commented, "The financing has allowed us to take advantage of the current low
interest rate environment to put into place long-term financing for our two
recent acquisitions, and increase our ability to borrow against our revolving
credit facility for general corporate needs."

     Henry Schein, Inc. is the largest distributor of healthcare products and
services to office-based healthcare practitioners, including dental practices
and laboratories, physician practices and veterinary clinics. The Company,
recognized for its excellent customer service and low prices, serves more than
300,000 customers worldwide. Headquartered in Melville, New York, the Company
employs over 6,000 people in 16 countries. Sales in 1998 were $1.9 billion. For
more information, visit the Henry Schein website at http://www.henryschein.com.

     Certain information contained herein includes information that is forward
looking. The matters referred to in forward looking statements may be affected
by the risks and uncertainties involved in the Company's business. These forward
looking statements are qualified in their entirety by the cautionary statements
contained in the Company's Securities and Exchange Commission filings.

                                       ###